NWF Advisory Services’s AstraZeneca AZN Stock Holding History

NWF Advisory Services’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$675K	Sell	3,485 -25	-0.7%	-$4.82K	0.08%	174
2025 Q4	$645K	Sell	3,510 -26	-0.7%	-$4.56K	0.07%	171
2025 Q3	$542K	Sell	3,536 -803	-19%	-$122K	0.06%	203
2025 Q2	$606K	Buy	+4,339	New	+$608K	0.07%	184
2024 Q4	–	Sell	-1,698	Closed	-$265K	–	293
2024 Q3	$265K	Buy	+1,698	New	+$274K	0.04%	261

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

NWF Advisory Services's AZN Position: Q1 2026 in Review

NWF Advisory Services reduced its AstraZeneca (AZN) stake by 0.71% in Q1 2026, selling an estimated $4.82K and leaving 3,485 shares worth $675K. The position accounts for 0.08% of the portfolio, ranked #174.

NWF Advisory Services first reported a position in AZN in Q3 2024 and has held it in 5 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

NWF Advisory Services held 3,485 shares of AstraZeneca worth $675K as of Q1 2026.
NWF Advisory Services sold 25 AstraZeneca shares in Q1 2026, an estimated $4.82K.
AstraZeneca made up 0.08% of NWF Advisory Services's portfolio in Q1 2026, its #174 holding.
NWF Advisory Services first reported a position in AstraZeneca in Q3 2024 and has held it in 5 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on NWF Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.